Form 4 for BDTX Black Diamond Therapeutics, Inc.
Accepted 2022-04-14 00:00:00 ET · period of report 2022-04-12 · accession 0000899243-22-014768 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-04-14 | 2022-04-12+ | BDTX | BIOTECH GROWTH N V | 10% | P - Purchase | $3.48 | +252.6K | 3.89M | +7% | +$879.1K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-04-13 | P | A | 102,556 | $3.57 | 3,988,402 | D | — | — | |
| 2 | Common | Common Stock | 2022-04-12 | P | A | 150,000 | $3.42 | 3,885,846 | D | — | — |